Financhill
Buy
58

PTCT Quote, Financials, Valuation and Earnings

Last price:
$77.53
Seasonality move :
-2.13%
Day range:
$77.02 - $79.87
52-week range:
$35.95 - $87.50
Dividend yield:
0%
P/E ratio:
8.98x
P/S ratio:
3.55x
P/B ratio:
--
Volume:
1.6M
Avg. volume:
1.8M
1-year change:
72.14%
Market cap:
$6.2B
Revenue:
$806.8M
EPS (TTM):
$8.56

PTC Therapeutics, Inc. SEC Filings

Company Filed Form Type Description
PTCT
PTC Therapeutics, Inc.
04/25/2024 10-Q 10-Q filing on 04/25/2024 View Form
PTCT
PTC Therapeutics, Inc.
10/26/2023 10-Q 10-Q filing on 10/26/2023 View Form
PTCT
PTC Therapeutics, Inc.
08/03/2023 10-Q 10-Q filing on 08/03/2023 View Form
PTCT
PTC Therapeutics, Inc.
04/27/2023 10-Q 10-Q filing on 04/27/2023 View Form
PTCT
PTC Therapeutics, Inc.
10/27/2022 10-Q 10-Q filing on 10/27/2022 View Form
PTCT
PTC Therapeutics, Inc.
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
PTCT
PTC Therapeutics, Inc.
05/03/2022 10-Q 10-Q filing on 05/03/2022 View Form
PTCT
PTC Therapeutics, Inc.
10/28/2021 10-Q 10-Q filing on 10/28/2021 View Form
PTCT
PTC Therapeutics, Inc.
07/29/2021 10-Q 10-Q filing on 07/29/2021 View Form
PTCT
PTC Therapeutics, Inc.
05/04/2021 10-Q 10-Q filing on 05/04/2021 View Form
PTCT
PTC Therapeutics, Inc.
10/29/2020 10-Q 10-Q filing on 10/29/2020 View Form
PTCT
PTC Therapeutics, Inc.
08/05/2020 10-Q 10-Q filing on 08/05/2020 View Form
PTCT
PTC Therapeutics, Inc.
04/30/2020 10-Q 10-Q filing on 04/30/2020 View Form
PTCT
PTC Therapeutics, Inc.
03/02/2020 10-K 10-K filing on 03/02/2020 View Form
PTCT
PTC Therapeutics, Inc.
10/30/2019 10-Q 10-Q filing on 10/30/2019 View Form
PTCT
PTC Therapeutics, Inc.
08/06/2019 10-Q 10-Q filing on 08/06/2019 View Form
PTCT
PTC Therapeutics, Inc.
05/02/2019 10-Q 10-Q filing on 05/02/2019 View Form
PTCT
PTC Therapeutics, Inc.
03/01/2019 10-K 10-K filing on 03/01/2019 View Form
PTCT
PTC Therapeutics, Inc.
11/05/2018 10-Q 10-Q filing on 11/05/2018 View Form
PTCT
PTC Therapeutics, Inc.
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
PTCT
PTC Therapeutics, Inc.
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
PTCT
PTC Therapeutics, Inc.
03/06/2018 10-K 10-K filing on 03/06/2018 View Form
PTCT
PTC Therapeutics, Inc.
11/02/2017 10-Q 10-Q filing on 11/02/2017 View Form
PTCT
PTC Therapeutics, Inc.
08/09/2017 10-Q 10-Q filing on 08/09/2017 View Form
PTCT
PTC Therapeutics, Inc.
05/08/2017 10-Q 10-Q filing on 05/08/2017 View Form
PTCT
PTC Therapeutics, Inc.
03/16/2017 10-K 10-K filing on 03/16/2017 View Form
PTCT
PTC Therapeutics, Inc.
11/03/2016 10-Q 10-Q filing on 11/03/2016 View Form
PTCT
PTC Therapeutics, Inc.
08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
PTCT
PTC Therapeutics, Inc.
05/05/2016 10-Q 10-Q filing on 05/05/2016 View Form
PTCT
PTC Therapeutics, Inc.
02/29/2016 10-K 10-K filing on 02/29/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Why Did Planet Labs Stock Rally So Much?
Why Did Planet Labs Stock Rally So Much?

Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
65
RGC alert for Jan 10

Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.

Sell
50
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock